Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy
- 8 May 2008
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 127 (3), 208-218
- https://doi.org/10.1016/j.jconrel.2008.01.013
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: Mechanisms, key factors, and their implicationsBiomaterials, 2007
- pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxelInternational Journal of Pharmaceutics, 2006
- Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxelJournal of Controlled Release, 2006
- Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stabilityInternational Journal of Pharmaceutics, 2006
- Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene deliveryJournal of Controlled Release, 2005
- Physicochemical Characteristics of Self-Assembled Nanoparticles Based on Glycol Chitosan Bearing 5β-Cholanic AcidLangmuir, 2003
- Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effectJournal of Controlled Release, 2003
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- Kinetic Studies of the Hydrolysis and Lactonization of Camptothecin and Its Derivatives, CPT-11 and SN-38, in Aqueous Solution.CHEMICAL & PHARMACEUTICAL BULLETIN, 1994
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966